Bausch Health Companies | VRX - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
7.85
Cambio Giornaliero
-0.04 -0.51%
Mensile
14.10%
Annuale
24.21%
Q2 Previsione
7.59




Spese Di Vendita E Di Amministrazione Cambiamento Data
Amgen USD 1.94B 237M 2025-12
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Bausch Health Companies USD 801M 6M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Danaher USD 2.03B 35M 2025-12
Drreddys Laboratories INR 26.92B 3.74B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novo Nordisk DKK 17.44B 1.41B 2025-12
Pacira USD 91.87M 70K 2025-12
Perrigo USD 255.9M 10.2M 2025-12
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Zoetis USD 619M 40M 2025-12